Cervical cancer is one of the most deadly types of cancer in women. Cervical cancer ranks second for the type of cancer that attacks women the most. Data from the Indonesian Ministry of Health, there are at least 15000 cases of cervical cancer every year in Indonesia. This cancer is a type of tumor that develops in the epithelial tissue of the cervix. In addition to HPV vaccination, cervical cancer detection can also be carried out with a Pap smear test and VIA examination supported by medical image tests such as CT scan, microscopic, and MRI. Pap smear test is a type of test to detect cervical cancer which is quite widely used because the cost of the test is cheaper than the HPV vaccination. This test is carried out by taking samples of uterine cells which are then analyzed for early detection of cervical cancer. Through a pap smear can be found the presence of HPV infection and abnormal cells that can turn into cancer cells. The purpose of this research is to apply the ResNet50 and ResNet101 architectures on pap smear images to identify cervical cancer and evaluate the performance of the ResNet50 and ResNet101 architectures in the classification of cervical cancer on pap smear images. In this study, CNN ResNet50 and ResNet101 were used to classify cervical cancer on pap smear images. This study has created two models to predict the grade of cervical cancer on pap smear images. The ResNet50 architecture gets 91% accuracy while the Res-Net101 architecture gets 89%. Although the architecture of ResNet101 is more complex than ResNet50, if viewed from the results of the model evaluation, ResNet101 has worse performance. This is due to the relatively small training data when trained with a large architecture such as ResNet101, not necessarily resulting in better accuracy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.